Aurora Investment Counsel Supernus Pharmaceuticals, Inc. Transaction History

Aurora Investment Counsel

  • $172 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 17, 2021
SELL
$23.54 - $31.39 $11,534 - $15,381
-490 Reduced 1.16%
41,668 $1.11 Million
Q2 2021

Aug 11, 2021
SELL
$26.72 - $33.19 $1,790 - $2,223
-67 Reduced 0.16%
42,158 $1.3 Million
Q1 2021

May 17, 2021
BUY
$24.15 - $31.45 $1.02 Million - $1.33 Million
42,225 New
42,225 $1.11 Million

Others Institutions Holding SUPN

# of Institutions
283
Shares Held
60.6M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.11B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Aurora Investment Counsel Portfolio

Follow Aurora Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Aurora Investment Counsel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email